Radioactive Gold Isotopes in the Era of Theranostics: Medical Potential of ¹⁹⁸Au and ¹⁹⁹Au Radioisotopes
Nuklearmedizin - NuclearMedicine · 01.04.2026 · 65 (02) · 69-82
DOI: 10.1055/a-2784-7716 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.04.2026. Verfasst von Punita Bhardwaj und 3 weiteren Autor:innen. Beteiligte Einrichtung: Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Nuclear Medicine Department, B…. Hauptthemen laut MEDLINE: Theranostic Nanomedicine, Gold, Radiopharmaceuticals, Radioisotopes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 123 Literaturangaben.
Abstract (Originalsprache)
Radioactive gold isotopes, particularly the element-matched theranostic pair 198Au and 199Au, hold significant promise for targeted radionuclide therapy and SPECT imaging. This review critically evaluates their medical potential by contextualizing historical development, nuclear properties, production physics, radiochemical separations, and contemporary radiopharmaceutical applications to identify pathways for clinical translation. We comprehensively surveyed literature on gold isotope decay characteristics, reactor and accelerator based production from Au, Pt, and Hg targets, purification strategies including ion-exchange chromatography, solid-phase extraction, polymer/zeolite adsorption, and liquid-liquid extraction, alongside reviewing a spectrum of 198Au/199Au radiotracers from small-molecule complexes to nanostructures and bioconjugates. 198Au and 199Au offer complementary β− emissions for therapy and their γ photons are ideal for SPECT imaging, with scalable carrier-added production routes from 197Au and non-carrier-added routes via enriched Pt/Hg. Robust separation techniques deliver radioactive gold with higher purity, enabling the production of diverse agents including but not limited to Au(III) Schiff-bases, phosphine/dithiocarbamate/NHC complexes, thioglucose derivatives, intrinsically doped nanoparticles (RGD-, bombesin-, HER2-targeted), and antibody conjugates. While radioactive gold research has progressed from colloidal 198Au brachytherapy to modern small molecule based complexes, barriers persist in sustainable high-specific-activity production, target recycling, in vivo stability, and clinical validation. Nevertheless, gold's chemical and physical characteristics position 198Au/199Au as candidates for next-generation radio-theranostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Nuclear Medicine Department, Berlin, Germany.
Zitieren
APA
Bhardwaj, P., Claude, G., Brenner, W., & Spreckelmeyer, S. (2026). Radioactive Gold Isotopes in the Era of Theranostics: Medical Potential of ¹⁹⁸Au and ¹⁹⁹Au Radioisotopes. Nuklearmedizin - NuclearMedicine, 65(02), 69-82. https://doi.org/10.1055/a-2784-7716
Vancouver
Bhardwaj P, Claude G, Brenner W, Spreckelmeyer S. Radioactive Gold Isotopes in the Era of Theranostics: Medical Potential of ¹⁹⁸Au and ¹⁹⁹Au Radioisotopes. Nuklearmedizin - NuclearMedicine. 2026;65(02):69-82. doi:10.1055/a-2784-7716
BibTeX
@article{Bhardwaj2026,
author = {Bhardwaj, Punita and Claude, Guilhem and Brenner, Winfried and Spreckelmeyer, Sarah},
title = {Radioactive Gold Isotopes in the Era of Theranostics: Medical Potential of ¹⁹⁸Au and ¹⁹⁹Au Radioisotopes},
journal = {Nuklearmedizin - NuclearMedicine},
year = {2026},
volume = {65},
number = {02},
pages = {69--82},
doi = {10.1055/a-2784-7716}
}
EUVIMED